NASDAQ:BWAY BrainsWay (BWAY) Stock Price, News & Analysis $10.00 +0.05 (+0.50%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends About BrainsWay Stock (NASDAQ:BWAY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BrainsWay alerts:Sign Up Key Stats Today's Range$9.89▼$10.1650-Day Range$7.15▼$10.2852-Week Range$3.37▼$10.61Volume45,470 shsAverage Volume94,984 shsMarket Capitalization$166.78 millionP/E Ratio200.04Dividend YieldN/APrice Target$13.17Consensus RatingModerate Buy Company OverviewBrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.Read More… The secret supplier behind NVIDIA, Tesla and Microsoft (Ad)The Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known supplier, which provides a crucial building block for AI.Click here for the ticker >>> BrainsWay Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks59th Percentile Overall ScoreBWAY MarketRank™: BrainsWay scored higher than 59% of companies evaluated by MarketBeat, and ranked 512th out of 993 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingBrainsWay has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageBrainsWay has only been the subject of 2 research reports in the past 90 days.Read more about BrainsWay's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth100.00% Earnings GrowthEarnings for BrainsWay are expected to grow by 100.00% in the coming year, from $0.06 to $0.12 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BrainsWay is 200.04, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 133.70.Price to Earnings Ratio vs. SectorThe P/E ratio of BrainsWay is 200.04, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 131.93.Price to Book Value per Share RatioBrainsWay has a P/B Ratio of 4.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about BrainsWay's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.28% of the outstanding shares of BrainsWay have been sold short.Short Interest Ratio / Days to CoverBrainsWay has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in BrainsWay has recently increased by 59.31%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBrainsWay does not currently pay a dividend.Dividend GrowthBrainsWay does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.28% of the outstanding shares of BrainsWay have been sold short.Short Interest Ratio / Days to CoverBrainsWay has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in BrainsWay has recently increased by 59.31%, indicating that investor sentiment is decreasing significantly. News and Social Media1.7 / 5News Sentiment-0.02 News SentimentBrainsWay has a news sentiment score of -0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for BrainsWay this week, compared to 2 articles on an average week.Search InterestOnly 8 people have searched for BWAY on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.MarketBeat Follows4 people have added BrainsWay to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BrainsWay insiders have not sold or bought any company stock.Percentage Held by Insiders19.00% of the stock of BrainsWay is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 30.11% of the stock of BrainsWay is held by institutions.Read more about BrainsWay's insider trading history. Receive BWAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BrainsWay and its competitors with MarketBeat's FREE daily newsletter. Email Address BWAY Stock News HeadlinesBrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024October 29 at 8:00 AM | globenewswire.comFY2025 EPS Estimate for BrainsWay Decreased by AnalystOctober 25, 2024 | americanbankingnews.com$5k to $1.3m in just 3 tradesIt doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.October 31, 2024 | Insiders Exposed (Ad)HC Wainwright Has Bearish Estimate for BrainsWay Q3 EarningsOctober 23, 2024 | americanbankingnews.comBrainsWay's (BWAY) "Buy" Rating Reiterated at HC WainwrightOctober 23, 2024 | americanbankingnews.comBrainsWay Expands Deep TMS Reach in East AsiaOctober 10, 2024 | finance.yahoo.comBrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South KoreaOctober 9, 2024 | globenewswire.comBrainsWay (NASDAQ:BWAY) Stock Quotes, Forecast and News SummaryOctober 1, 2024 | benzinga.comSee More Headlines BWAY Stock Analysis - Frequently Asked Questions How have BWAY shares performed this year? BrainsWay's stock was trading at $6.48 at the beginning of 2024. Since then, BWAY stock has increased by 54.3% and is now trading at $10.00. View the best growth stocks for 2024 here. How were BrainsWay's earnings last quarter? BrainsWay Ltd. (NASDAQ:BWAY) released its earnings results on Tuesday, August, 6th. The company reported $0.04 EPS for the quarter. The company earned $10.01 million during the quarter, compared to the consensus estimate of $9.40 million. BrainsWay had a trailing twelve-month return on equity of 1.45% and a net margin of 1.67%. When did BrainsWay IPO? BrainsWay (BWAY) raised $30 million in an IPO on Wednesday, April 17th 2019. The company issued 2,500,000 shares at $11.94 per share. Cantor acted as the underwriter for the IPO. Who are BrainsWay's major shareholders? Top institutional shareholders of BrainsWay include Good Life Advisors LLC (0.33%). How do I buy shares of BrainsWay? Shares of BWAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of BrainsWay own? Based on aggregate information from My MarketBeat watchlists, some other companies that BrainsWay investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Novo Nordisk A/S (NVO) and AppLovin (APP). Company Calendar Last Earnings8/06/2024Today10/31/2024Next Earnings (Confirmed)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:BWAY CUSIPN/A CIK1505065 Webwww.brainsway.com Phone(722) 582-4030FaxN/AEmployees120Year FoundedN/APrice Target and Rating Average Stock Price Target$13.17 High Stock Price Target$16.00 Low Stock Price Target$11.00 Potential Upside/Downside+32.3%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.09) Trailing P/E Ratio199.04 Forward P/E Ratio165.83 P/E GrowthN/ANet Income$-4,200,000.00 Net Margins1.67% Pretax Margin2.14% Return on Equity1.45% Return on Assets0.96% Debt Debt-to-Equity RatioN/A Current Ratio4.70 Quick Ratio4.39 Sales & Book Value Annual Sales$36.43 million Price / Sales4.56 Cash FlowN/A Price / Cash FlowN/A Book Value$2.50 per share Price / Book3.98Miscellaneous Outstanding Shares16,678,000Free Float13,509,000Market Cap$165.95 million OptionableNot Optionable Beta1.26 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report This page (NASDAQ:BWAY) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BrainsWay Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BrainsWay With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.